Cell line · CVCL_1847
PaTu 8988t
Cancer cell line, Homo sapiens. Pancreatic adenocarcinoma. 60 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. PaTu 8988t. Cell lines, record CVCL_1847. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1847
On this page
Cell line
As Cellosaurus gives it.
- Name
- PaTu 8988t
- Accession
- CVCL_1847
- RRID
- RRID:CVCL_1847
- Synonyms
- PA-TU-8988T, PaTu8988t, PaTu8988T, PATU8988T, PaTu 8988 T, PaTu-8988t, PATU-8988T, PATU-T, PA-TU T, 8988T, PaCL4
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 64Y
- Category
- Cancer cell line
- Diseases
- Pancreatic adenocarcinoma (NCIt C8294)
- Derived from
- Liver (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers60
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Selective AUTAC-mediated ATP7B degradation unlocks cuproptosis vulnerability in pancreatic ductal adenocarcinoma. | Clin Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| KDM6A loss enhances oxidative phosphorylation uncovering tissue-level convergent evolution. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma. | Cell Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combining ferroptosis inducers with gemcitabine to enhance treatment efficacy in pancreatic cancer. | Cancer Metab | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Metal-Free Carbon Monoxide Prodrug Suppresses Metastasis of Pancreatic and Breast Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Extracellular matrix sensing regulates intratumoral heterogeneity of autophagic flux. | Cell | 2026 | Its Methods give the RRID and name the line | PubMed | |
| IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 60
See all 60 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE HMGA1 (p.K7R, c.20A>G) Point Mutation in PaTu 8988t Cell Line | CVCL_F6D7 | Cell lines | |
| From the same person | PaTu 8988s | CVCL_1846 | Cell lines |
Cell banks2
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1847
GET https://conductscience.org/api/cell-lines/v1/CVCL_1847/papers?page=2